The Global COVID-19 Saliva Sampling Test Potential Industry is expected to experience significant growth, according to a recent report from Future Market Insights (FMI), a leading market research and competitive intelligence provider. This growth is attributed to the emergence of new, more transmissible SARS-CoV-2 variants, highlighting the need for efficient and convenient testing methods.
FMI’s comprehensive analysis reveals that the market, valued at US$ 3.1 billion in 2021, is projected to reach US$ 5.4 billion by 2032. This translates to a steady Compound Annual Growth Rate (CAGR) of 5.1% over the forecast period.
The key driver behind this anticipated growth is the prominence of fluorescence-labeled antigen/antibody testing, projected to exhibit the highest CAGR of over 5.1%. This testing method offers a range of advantages, including user-friendliness, a shorter test-to-result timeline, and a patient-friendly nature.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14945
The market for COVID-19 Saliva Sampling Test Potential is dominated by companies such as ARUP Laboratories, Vatic Health, Mogene, Psomagen Inc, and DxTerity Diagnostics Inc. North American region has become the world’s leading market for COVID-19 saliva Sampling tests due to the introduction of several new products by emerging companies, as well as the presence of homegrown firms that manufacture diagnostic and Sampling tests based on various technologies.
Centralized Testing commanded the highest growth through the forecast period of 2022-2032 with a CAGR of 5.1%. Some of the main reasons for the strong emphasis on saliva-based COVID-19 diagnosis across centralized settings are the ease of use of sample collection, reduction in the amount of supplies necessary for saliva testing, and reduction in testing procedures.
Key Takeaways from the Global COVID-19 Saliva Sampling Test Potential Industry Study
- The COVID-19 Saliva Sampling Test Potential market is anticipated to add 1.6X value by 2032.
- The market is expected to expand at a considerable growth rate of 5.1% and be valued at US$ 5.4 Bn by 2032.
- ARUP Laboratories, Vatic Health, Mogene, Psomagen Inc., and DxTerity Diagnostics Inc. are the top giants in COVID-19 Saliva Sampling Test Potential manufacturing.
- Based on technology, the Fluorescence-labelled antigen/antibodies Testing segment accounted for the majority of the global COVID-19 Saliva Sampling Test Potential market share in 2021.
- In April 2021, Vatic Health received the CE mark for its on-the-spot SARS-CoV-2 virus saliva antigen test. The test has also been registered with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom. Several major players are concentrating on advancements in in-vitro diagnostic procedures with rapid testing, as well as expanding their product portfolios.
“Saliva-based tests are crucial in sampling asymptomatic individuals, which will aid in market revenue generation shortly.” says a Future Market Insights analyst.
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14945
More Valuable Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the global COVID-19 Saliva Sampling Test Potential market, presenting historical market data (2019-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights by Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities and Colleges, and Factories), Technology (Fluorescence-labelled antigen/antibodies Testing, RT-PCR and CRISPR-Cas9), Mode (Centralized Testing and Decentralized Testing) and Region (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)
Global COVID-19 Saliva Sampling Test Potential Industry Key Companies Profiled
- ARUP Laboratories
- Vatic Health
- Mogene
- Psomagen Inc
- DxTerity Diagnostics Inc
- Chembio Diagnostics
- Abbott
Market Segments Covered in Global COVID-19 Saliva Sampling Test Potential Industry Analysis
By Location:
- Travel Stations
- Sports Arenas
- Entertainment Venues
- Corporate Campus Environments
- Universities & Colleges
- Factories
By Technology:
- Fluorescence-labeled antigen/antibodies testing
- RT-PCR
- CRISPR-Cas9
By Mode:
- Centralized Testing
- Decentralized Testing
By Region:
- North America
- Latin America
- Europe
- APAC
- MEA
Buy a Complete Research Report
https://www.futuremarketinsights.com/checkout/14945
Future Market Insights’s Domain Knowledge in Healthcare Division
Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analyzed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube